[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
Identifieur interne : 001E67 ( Main/Exploration ); précédent : 001E66; suivant : 001E68[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
Auteurs : Jean-Yves NauSource :
- Revue medicale suisse [ 1660-9379 ] ; 2013.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (administration et posologie), Antiviraux (usage thérapeutique), Association de médicaments, Coronavirus (pathogénicité), Diagnostic différentiel, Humains, Interféron alpha (administration et posologie), Interféron alpha (usage thérapeutique), Moyen Orient (épidémiologie), Ribavirine (administration et posologie), Ribavirine (usage thérapeutique), Résultat thérapeutique, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (virologie), Syndrome respiratoire aigu sévère (épidémiologie), Traitement d'urgence ().
- MESH :
- administration et posologie : Antiviraux, Interféron alpha, Ribavirine.
- diagnostic : Syndrome respiratoire aigu sévère.
- pathogénicité : Coronavirus.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux, Interféron alpha, Ribavirine, Syndrome respiratoire aigu sévère.
- virologie : Syndrome respiratoire aigu sévère.
- épidémiologie : Moyen Orient, Syndrome respiratoire aigu sévère.
- Animaux, Association de médicaments, Diagnostic différentiel, Humains, Résultat thérapeutique, Traitement d'urgence.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (administration & dosage), Antiviral Agents (therapeutic use), Coronavirus (pathogenicity), Diagnosis, Differential, Drug Therapy, Combination, Emergency Treatment (methods), Humans, Interferon-alpha (administration & dosage), Interferon-alpha (therapeutic use), Middle East (epidemiology), Ribavirin (administration & dosage), Ribavirin (therapeutic use), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (transmission), Severe Acute Respiratory Syndrome (virology), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Antiviral Agents, Interferon-alpha, Ribavirin.
- chemical , therapeutic use : Antiviral Agents, Interferon-alpha, Ribavirin.
- geographic , epidemiology : Middle East.
- diagnosis : Severe Acute Respiratory Syndrome.
- drug therapy : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome.
- methods : Emergency Treatment.
- pathogenicity : Coronavirus.
- transmission : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Diagnosis, Differential, Drug Therapy, Combination, Humans, Treatment Outcome.
PubMed: 23882919
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001C48
- to stream PubMed, to step Curation: 001C48
- to stream PubMed, to step Checkpoint: 001A27
- to stream Ncbi, to step Merge: 000A90
- to stream Ncbi, to step Curation: 000A90
- to stream Ncbi, to step Checkpoint: 000A90
- to stream Main, to step Merge: 001E82
- to stream Main, to step Curation: 001E67
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].</title><author><name sortKey="Nau, Jean Yves" sort="Nau, Jean Yves" uniqKey="Nau J" first="Jean-Yves" last="Nau">Jean-Yves Nau</name><affiliation><nlm:affiliation>jeanyves.nau@gmail.com</nlm:affiliation><wicri:noCountry code="no comma">jeanyves.nau@gmail.com</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23882919</idno><idno type="pmid">23882919</idno><idno type="wicri:Area/PubMed/Corpus">001C48</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C48</idno><idno type="wicri:Area/PubMed/Curation">001C48</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C48</idno><idno type="wicri:Area/PubMed/Checkpoint">001A27</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A27</idno><idno type="wicri:Area/Ncbi/Merge">000A90</idno><idno type="wicri:Area/Ncbi/Curation">000A90</idno><idno type="wicri:Area/Ncbi/Checkpoint">000A90</idno><idno type="wicri:doubleKey">1660-9379:2013:Nau J:emergency:treatment:for</idno><idno type="wicri:Area/Main/Merge">001E82</idno><idno type="wicri:Area/Main/Curation">001E67</idno><idno type="wicri:Area/Main/Exploration">001E67</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].</title><author><name sortKey="Nau, Jean Yves" sort="Nau, Jean Yves" uniqKey="Nau J" first="Jean-Yves" last="Nau">Jean-Yves Nau</name><affiliation><nlm:affiliation>jeanyves.nau@gmail.com</nlm:affiliation><wicri:noCountry code="no comma">jeanyves.nau@gmail.com</wicri:noCountry></affiliation></author></analytic><series><title level="j">Revue medicale suisse</title><idno type="ISSN">1660-9379</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (administration & dosage)</term><term>Antiviral Agents (therapeutic use)</term><term>Coronavirus (pathogenicity)</term><term>Diagnosis, Differential</term><term>Drug Therapy, Combination</term><term>Emergency Treatment (methods)</term><term>Humans</term><term>Interferon-alpha (administration & dosage)</term><term>Interferon-alpha (therapeutic use)</term><term>Middle East (epidemiology)</term><term>Ribavirin (administration & dosage)</term><term>Ribavirin (therapeutic use)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (administration et posologie)</term><term>Antiviraux (usage thérapeutique)</term><term>Association de médicaments</term><term>Coronavirus (pathogénicité)</term><term>Diagnostic différentiel</term><term>Humains</term><term>Interféron alpha (administration et posologie)</term><term>Interféron alpha (usage thérapeutique)</term><term>Moyen Orient (épidémiologie)</term><term>Ribavirine (administration et posologie)</term><term>Ribavirine (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Traitement d'urgence ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term><term>Interferon-alpha</term><term>Ribavirin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Interferon-alpha</term><term>Ribavirin</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Middle East</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term><term>Interféron alpha</term><term>Ribavirine</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Emergency Treatment</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Interféron alpha</term><term>Ribavirine</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Moyen Orient</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Diagnosis, Differential</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Association de médicaments</term><term>Diagnostic différentiel</term><term>Humains</term><term>Résultat thérapeutique</term><term>Traitement d'urgence</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list></list><tree><noCountry><name sortKey="Nau, Jean Yves" sort="Nau, Jean Yves" uniqKey="Nau J" first="Jean-Yves" last="Nau">Jean-Yves Nau</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E67 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E67 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23882919
|texte= [Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23882919" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |